Given that HDAC1 and HDAC2 play critical roles in neuronal differentiation, and that HDAC1 expression is reduced in AD, the design of inhibitors that spare or modulate these isoforms in a context-dependent manner becomes particularly important. This evidence concerns the gene HDAC2 and Alzheimer disease.